(Q37860933)

24 August 2017

title

A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes (English)

1 reference

24 August 2017

Lucinda Macmillan

1

1 reference

24 August 2017

Godwin O Ifere

2

1 reference

24 August 2017

Qing He

3

1 reference

24 August 2017

Joseph U Igietseme

4

1 reference

24 August 2017

Kathryn L Kellar

5

1 reference

24 August 2017

Daniel M Okenu

6

1 reference

24 August 2017

Francis O Eko

7

1 reference

24 August 2017

publication date

9 November 2006

1 reference

FEMS Immunology and Medical Microbiology

24 August 2017

published in

1 reference

24 August 2017

volume

49

1 reference

24 August 2017

issue

1

1 reference

24 August 2017

page(s)

46-55

1 reference

Sexually transmitted diseases: magnitude, determinants and consequences

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

Incidence of herpes simplex virus type 2 infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

Herpes simplex virus type 2 vaccines: new ground for optimism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

The acquisition of herpes simplex virus during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

A novel recombinant multisubunit vaccine against Chlamydia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

Association between human immunodeficiency virus and herpes simplex virus type 2 seropositivity among male factory workers in Zimbabwe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

The herpes simplex virus type 2 equivalent of the herpes simplex virus type 1 US7 gene and its flanking sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

Chlamydia vaccines: strategies and status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

Contemporary approaches to designing and evaluating vaccines against Chlamydia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

Comparative genomes of Chlamydia pneumoniae and C. trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

Inducible cell lysis system for the study of natural transformation and environmental fate of DNA released by cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

Immunity induced by DNA immunization with herpes simplex virus type 2 glycoproteins B and C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

Fc receptor regulation of protective immunity against Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

Animal models for urogenital infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

Vaccines against Chlamydia: approaches and progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

New developments in the epidemiology, natural history and management of genital herpes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1574-695X.2006.00165.X

10.1111/J.1574-695X.2006.00165.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference